5.76
price up icon12.30%   0.631
 
loading
Precedente Chiudi:
$5.129
Aprire:
$5.52
Volume 24 ore:
88,914
Relative Volume:
4.58
Capitalizzazione di mercato:
$7.59M
Reddito:
-
Utile/perdita netta:
$-38.35M
Rapporto P/E:
-3.9724
EPS:
-1.45
Flusso di cassa netto:
$-36.91M
1 W Prestazione:
+20.75%
1M Prestazione:
+22.55%
6M Prestazione:
-58.56%
1 anno Prestazione:
-65.09%
Intervallo 1D:
Value
$5.10
$5.80
Intervallo di 1 settimana:
Value
$4.60
$5.80
Portata 52W:
Value
$4.4006
$23.50

Galecto Inc Stock (GLTO) Company Profile

Name
Nome
Galecto Inc
Name
Telefono
45-70-70-52-10
Name
Indirizzo
75 STATE STREET, BOSTON
Name
Dipendente
13
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
GLTO's Discussions on Twitter

Confronta GLTO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GLTO
Galecto Inc
5.76 7.59M 0 -38.35M -36.91M -1.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Galecto Inc Stock (GLTO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-04-26 Ripresa Credit Suisse Outperform
2020-11-23 Iniziato BofA Securities Buy
2020-11-23 Iniziato Credit Suisse Outperform
2020-11-23 Iniziato SVB Leerink Outperform

Galecto Inc Borsa (GLTO) Ultime notizie

pulisher
Jan 17, 2025

Mustang Bio (NASDAQ:MBIO) Stock Quotes, Forecast and News Summary - Benzinga

Jan 17, 2025
pulisher
Jan 13, 2025

Analyzing Galecto (NASDAQ:GLTO) and Pasithea Therapeutics (NASDAQ:KTTA) - Defense World

Jan 13, 2025
pulisher
Jan 11, 2025

Where are the Opportunities in (GLTO) - Stock Traders Daily

Jan 11, 2025
pulisher
Jan 07, 2025

Galecto CEO Hans T. Schambye sells $7,509 in shares - Investing.com

Jan 07, 2025
pulisher
Jan 07, 2025

Galecto CEO Hans T. Schambye sells $7,509 in shares By Investing.com - Investing.com Canada

Jan 07, 2025
pulisher
Jan 03, 2025

Galecto (NASDAQ:GLTO) Shares Up 22.6% – Should You Buy? - Defense World

Jan 03, 2025
pulisher
Jan 01, 2025

When (GLTO) Moves Investors should Listen - Stock Traders Daily

Jan 01, 2025
pulisher
Dec 18, 2024

Galecto stock plunges to 52-week low at $4.78 amid market challenges - Investing.com Australia

Dec 18, 2024
pulisher
Dec 12, 2024

Galecto stock hits 52-week low at $5.26 amid market challenges - Investing.com Nigeria

Dec 12, 2024
pulisher
Dec 12, 2024

Galecto stock hits 52-week low at $5.26 amid market challenges By Investing.com - Investing.com South Africa

Dec 12, 2024
pulisher
Dec 09, 2024

(GLTO) Trading Signals - Stock Traders Daily

Dec 09, 2024
pulisher
Nov 27, 2024

Galecto stock hits 52-week low at $5.51 amid market challenges - Investing.com Australia

Nov 27, 2024
pulisher
Nov 26, 2024

GLTO (Galecto) Momentum Rank : 2 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 25, 2024

Idiopathic Pulmonary Fibrosis Market Report 2034, by DelveInsight | Companies: FibroGen, Hoffmann-La Roche Ltd, United Therapeutics, Boehringer Ingelheim, Pliant Therapeutics, Inc., Galecto Biotech - The Globe and Mail

Nov 25, 2024
pulisher
Nov 25, 2024

Idiopathic Pulmonary Fibrosis Market Report 2034, - openPR

Nov 25, 2024
pulisher
Nov 23, 2024

Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN

Nov 23, 2024
pulisher
Nov 22, 2024

GLTO (Galecto) EBITDA per Share : $-17.96 (TTM As of Sep. 2024) - GuruFocus.com

Nov 22, 2024
pulisher
Nov 19, 2024

Galecto (NASDAQ:GLTO) Shares Down 5.3% – Should You Sell? - Defense World

Nov 19, 2024
pulisher
Nov 15, 2024

Galecto stock hits 52-week low at $6.46 amid market challenges - Investing.com India

Nov 15, 2024
pulisher
Nov 12, 2024

Galecto Inc. (GLTO) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 08, 2024

(GLTO) Investment Report - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 06, 2024

Galecto, Inc.’s Strategic Shift to Oncology and Liver Diseases: Navigating Risks and Opportunities - MSN

Nov 06, 2024
pulisher
Nov 02, 2024

Galecto reports Q3 EPS ($3.39) vs ($7.50) - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Galecto, Inc. Announces Strategic Shift and Financial Overview - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Galecto Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 01, 2024
pulisher
Oct 28, 2024

(GLTO) On The My Stocks Page - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 28, 2024

Global Secondary Myelofibrosis Therapeutics Market Poised to Reach USD 2.74 Million by 2033 with a 6 - PharmiWeb.com

Oct 28, 2024
pulisher
Oct 18, 2024

Galecto price target raised to $10 from $9 at Oppenheimer - Yahoo Finance

Oct 18, 2024
pulisher
Oct 17, 2024

How to Take Advantage of moves in (GLTO) - Stock Traders Daily

Oct 17, 2024
pulisher
Oct 17, 2024

Galecto (NASDAQ:GLTO) Price Target Increased to $10.00 by Analysts at Oppenheimer - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Galecto (NASDAQ:GLTO) Given New $10.00 Price Target at Oppenheimer - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Galecto adds Dr. Amy Wechsler to Board of Directors By Investing.com - Investing.com Canada

Oct 16, 2024
pulisher
Oct 16, 2024

Galecto stock hits 52-week low at $6.61 amid market challenges - Investing.com Canada

Oct 16, 2024
pulisher
Oct 16, 2024

Galecto adds Dr. Amy Wechsler to Board of Directors - Investing.com

Oct 16, 2024
pulisher
Oct 15, 2024

Galecto Appoints Dr. Amy Wechsler to Board - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler - The Manila Times

Oct 15, 2024
pulisher
Oct 07, 2024

Galecto refocuses on cancer, acquires novel AML drug rights By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Clene Inc (CLNN-Q) QuotePress Release - The Globe and Mail

Oct 07, 2024
pulisher
Oct 07, 2024

Galecto stock hits 52-week low at $9.3 amid market challenges - Investing.com

Oct 07, 2024
pulisher
Oct 07, 2024

Galecto stock hits 52-week low at $9.3 amid market challenges By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Galecto Expands Oncology Portfolio with Strategic Acquisition - TipRanks

Oct 07, 2024

Galecto Inc Azioni (GLTO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):